Drug intelligence / Profile preview

fagopyrum esculentum extract

Development stage
Unknown
Administration
Oral
01

Overview

Fagopyrum esculentum extract refers to preparations made from various parts (leaves, flowers, hulls, or sprouts) of Fagopyrum esculentum, commonly known as buckwheat. These extracts are rich in flavonoids (notably rutin and quercetin), phenolic acids, and other phytochemicals. Buckwheat extracts have demonstrated multiple biological activities, including **antioxidant**, **anti-inflammatory**, **antitumor**, **antidiabetic**, **hepatoprotective**, and **vasoprotective** effects. Their mechanisms of action include scavenging free radicals, modulating inflammatory mediators (such as IL-6, TNF-α), improving oxidative stress status, inhibiting tumor cell proliferation and inducing cell cycle arrest and apoptosis in cancer cells, and enhancing vascular function. Buckwheat extracts have a long history of traditional use for conditions such as **varicose veins**, **hypertension**, **poor circulation**, **radiation damage**, and **gout**.

Other names
buckwheat extractfagopyrum esculentum flower and leaf extractfagopyrum esculentum hull extractbuckwheat hull extractcommon buckwheat extract
02

Targets

IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on fagopyrum esculentum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fagopyrum esculentum extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call